Paper33183151
Discovery and characterization of a neutralizing pan-ELR+CXC chemokine monoclonal antibody.
Boyles JS and 10 others. MAbs, 2020. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Discovery and characterization of a neutralizing pan-ELR+CXC chemokine monoclonal antibody. Papers, record 33183151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33183151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Discovery and characterization of a neutralizing pan-ELR+CXC chemokine monoclonal antibody.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antibodies, Neutralizing | Major topic |
| Receptors, Interleukin-8A | Major topic |
| Receptors, Interleukin-8B | Major topic |
| Animals | |
| Antibody Affinity | |
| Chemotaxis, Leukocyte | |
| Humans | |
| Macaca fascicularis | |
| Mice | |
| Neutrophils | |
| Rats |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19299620 | Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site. | Science | 2009 | https://conductscience.org/library/papers/19299620 | PubMed |
| 2 | 10699158 | International union of pharmacology. XXII. Nomenclature for chemokine receptors. | Pharmacol Rev | 2000 | https://conductscience.org/library/papers/10699158 | PubMed |
| 3 | 28028310 | Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures. | Nat Rev Immunol | 2017 | https://conductscience.org/library/papers/28028310 | PubMed |
| 4 | 26607389 | Successes and failures of chemokine-pathway targeting in rheumatoid arthritis. | Nat Rev Rheumatol | 2016 | https://conductscience.org/library/papers/26607389 | PubMed |
| 5 | 19276354 | A role for CXCR2 in senescence, but what about in cancer? | Cancer Res | 2009 | https://conductscience.org/library/papers/19276354 | PubMed |
| 6 | 31848188 | Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models. | Clin Cancer Res | 2020 | https://conductscience.org/library/papers/31848188 | PubMed |
| 7 | 10496309 | Fully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states. | J Leukoc Biol | 1999 | https://conductscience.org/library/papers/10496309 | PubMed |
| 8 | 6502707 | Analysis of membrane and surface protein sequences with the hydrophobic moment plot. | J Mol Biol | 1984 | https://conductscience.org/library/papers/6502707 | PubMed |
| 9 | 18980965 | The interleukin-8 pathway in cancer. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18980965 | PubMed |
| 10 | 28539464 | Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28539464 | PubMed |
| 11 | 3881765 | Rapid and efficient site-specific mutagenesis without phenotypic selection. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3881765 | PubMed |
| 12 | 21460441 | Overview of the CCP4 suite and current developments. | Acta Crystallogr D Biol Crystallogr | 2011 | https://conductscience.org/library/papers/21460441 | PubMed |
| 13 | 25753743 | Targeting chemokines: Pathogens can, why can't we? | Cytokine | 2015 | https://conductscience.org/library/papers/25753743 | PubMed |
| 14 | 25736418 | Pharmacological characterization of AZD5069, a slowly reversible CXC chemokine receptor 2 antagonist. | J Pharmacol Exp Ther | 2015 | https://conductscience.org/library/papers/25736418 | PubMed |
| 15 | 19431209 | CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer. | Int J Cancer | 2009 | https://conductscience.org/library/papers/19431209 | PubMed |
| 16 | 31153737 | The Neutrophil Life Cycle. | Trends Immunol | 2019 | https://conductscience.org/library/papers/31153737 | PubMed |
| 17 | 15282370 | Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15282370 | PubMed |
| 18 | 30913963 | Development of a high-throughput solubility screening assay for use in antibody discovery. | MAbs | 2019 | https://conductscience.org/library/papers/30913963 | PubMed |
| 19 | 28529637 | Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases. | Theranostics | 2017 | https://conductscience.org/library/papers/28529637 | PubMed |
| 20 | 31924241 | A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer. | Breast Cancer Res | 2020 | https://conductscience.org/library/papers/31924241 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41863659 | Decoding Neuroinflammatory Pathways: The Role of the CXCL12-CXCR4/CXCR7 Axis in ALS-Related Cognitive Impairment. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/41863659 | PubMed |
| 41752212 | Targeting Neutrophil Function as Therapy for Hidradenitis Suppurativa. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41752212 | PubMed |
| 40427171 | The CXCL1-CXCR2 Axis as a Component of Therapy Resistance, a Source of Side Effects in Cancer Treatment, and a Therapeutic Target. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40427171 | PubMed |
| 39978339 | Molecular basis of promiscuous chemokine binding and structural mimicry at the C-X-C chemokine receptor, CXCR2. | Mol Cell | 2025 | https://conductscience.org/library/papers/39978339 | PubMed |
| 39409185 | Insights of Expression Profile of Chemokine Family in Inflammatory Bowel Diseases and Carcinogenesis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39409185 | PubMed |
| 38215184 | The immunoglobulin J chain is an evolutionarily co-opted chemokine. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38215184 | PubMed |
| 38047990 | Structure, function and drug discovery of GPCR signaling. | Mol Biomed | 2023 | https://conductscience.org/library/papers/38047990 | PubMed |
| 37760412 | In Vitro and In Silico Investigation of BCI Anticancer Properties and Its Potential for Chemotherapy-Combined Treatments. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37760412 | PubMed |
| 37402031 | Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies. | Dermatol Ther (Heidelb) | 2023 | https://conductscience.org/library/papers/37402031 | PubMed |
| 36794755 | Endothelial cells overexpressing CXCR1/2 are renoprotective in rats with acute kidney injury. | Am J Physiol Renal Physiol | 2023 | https://conductscience.org/library/papers/36794755 | PubMed |
| 36692663 | Pharmacological heat-shock protein inducers and chemical chaperones inhibit upregulation of interleukin-8 by oxidized phospholipids. | Inflammopharmacology | 2023 | https://conductscience.org/library/papers/36692663 | PubMed |
| 36624516 | Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis. | Mol Cancer | 2023 | https://conductscience.org/library/papers/36624516 | PubMed |
| 35672352 | Network pharmacology and experimental verification based research into the effect and mechanism of Aucklandiae Radix-Amomi Fructus against gastric cancer. | Sci Rep | 2022 | https://conductscience.org/library/papers/35672352 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33183151
GET https://conductscience.org/api/papers/v1/33183151/references?page=2